Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. BDB554547

IFN-γ Mouse anti-Human, NA/LE, Unlabeled, Clone: NIB42, BD

Catalog No. BDB554547 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
0.5 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB554547 0.5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB554547 Supplier BD Biosciences Supplier No. 554547
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

The NIB42 antibody reacts with human interferon-gamma (IFN-γ). The immunogen used to generate the NIB42 hybridoma was recombinant human IFN-γ. This is a neutralizing antibody.

TRUSTED_SUSTAINABILITY

Specifications

Antigen IFN-γ
Applications ELISA
Classification Monoclonal
Clone NIB42
Concentration 1.0mg/mL
Conjugate Unconjugated
Formulation No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2μm sterile filtered. Endotoxin level is ≤0.01 EU/μg (≤0.001 ng/μg) of protein as determined by the LAL assay.
Host Species Mouse
Immunogen Recombinant human IFN-γ
Purification Method Affinity Purified
Quantity 0.5 mg
Regulatory Status RUO
Research Discipline Immunology
Primary or Secondary Primary
Target Species Human
Content And Storage Store undiluted at 4°C
Isotype IgG1 κ
Show More Show Less

Safety and Handling

WARNING: Reproductive Harm - www.P65Warnings.ca.gov

For Research Use Only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.